Identifying baseline rectal MRI features as predictive indicators for local recurrence and metastatic disease in rectal cancer treated with surgical resection and neoadjuvant therapy or surgical resection alone

Colorectal cancer is the third most common cancer worldwide and accounts for the second highest number of cancer deaths [1]. Of note, although the overall incidence of colorectal cancer has been decreasing in the past few years, there has been an increase in the incidence of colorectal cancer in patients younger than 50 years of age [1,2]. In the United States, colorectal cancer was responsible for 8.6 % of all cancer deaths in 2022 and the 5-year survival rate of colorectal cancer was 65.1 % fr…

Read the full article on ejradiology.com